CARISMA THERAPEUTICS INC (CARM:NASDAQ)
$0.0061 0.0004 (7.0175%)
Analysed CARISMA THERAPEUTICS INC (CARM:NASDAQ) News Sources
Carisma Therapeutics and OrthoCellix Enter into Definitive Merger Agreement to Create Company Focused on Regenerative Cell Therapies for Orthopedic Diseases
23-06-2025
yahoo.com
Carisma Therapeutics, OrthoCellix enter definitive merger agreement
24-06-2025
yahoo.com
BC-Most Active Stocks
02-09-2025
yahoo.com
Carisma Announces Delisting from Nasdaq and SEC Deregistration
05-12-2025
yahoo.com
Liberate Bio Secures Myeloid-Optimized CAR Design Licenses to Advance In Vivo CAR-M Programs
05-03-2026
yahoo.com
Liberate Bio gains licences for myeloid-specific CAR design patents
06-03-2026
hospitalmanagement.net
Carmila Makes its 2025 Universal Registration Document Available
01-04-2026
yahoo.com
CARMILA: Information Concerning the Total Number of Voting Rights and Share
02-04-2026
yahoo.com
ProKidney Appoints Kenneth Locke as Chief Technical Officer
02-06-2026
yahoo.com
What is the current price of CARISMA THERAPEUTICS INC (CARM:NASDAQ)?
The current price of CARISMA THERAPEUTICS INC (CARM:NASDAQ) is $0.0061.
CARISMA THERAPEUTICS INC (CARM:NASDAQ) absolute price change since previous trading day?
The absolute price change of CARISMA THERAPEUTICS INC (CARM:NASDAQ) since the previous trading day is $0.0004.
CARISMA THERAPEUTICS INC (CARM:NASDAQ) percentage price change since previous trading day?
The percentage price change of CARISMA THERAPEUTICS INC (CARM:NASDAQ) since the previous trading day is 7.0175%.
What is the most recent average sentiment score for CARISMA THERAPEUTICS INC (CARM:NASDAQ)?
The most recent average sentiment score for CARISMA THERAPEUTICS INC (CARM:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for CARISMA THERAPEUTICS INC (CARM:NASDAQ)?
The most recent sentiment for CARISMA THERAPEUTICS INC (CARM:NASDAQ) is .
SEC-8K** Filing Available For CARISMA THERAPEUTICS INC (CARM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.